Home Dermatology PDF: Update on Drugs & Devices: January – February 2019
PDF: Update on Drugs & Devices: January – February 2019
$1.99
PDF Download: Update on Dalbavancin hydrochloride for IV infusion (Xydalba™), Omadacycline for IV and oral use (Nuzyra™), Tildrakizumab-asmn for SC injection (Ilumya™), Adalimumab-adaz for SC injection (Hyrimoz™) and other new drugs and treatments.